Advertisement

Reactions Weekly

, Volume 1765, Issue 1, pp 158–158 | Cite as

Erlotinib/osimertinib

Development of resistance in lung adenocarcinoma: case report
Case report
  • 15 Downloads

Reference

  1. Patro M, et al. A "triple whammy" in adenocarcinoma lung. Lung India 36: 340-344, No. 4, Jul-Aug 2019. Available from: URL: http://doi.org/10.4103/lungindia.lungindia_212_18 - India

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations